Abstract
We evaluated 113 pediatric patients with chronic hepatitis C from 2009 to 2019 at a Brazilian tertiary center. Seventy patients received pegylated-interferon treatment. The sustained virologic response was 61.4%, and 92.8% reported side effects. Currently, we are following 39 patients with chronic hepatitis C, 24 of whom are eligible for treatment with direct-acting antivirals according to Brazilian recommendations.
MeSH terms
-
Adolescent
-
Antiviral Agents / standards
-
Antiviral Agents / therapeutic use*
-
Brazil
-
Child
-
Child, Preschool
-
Drug Therapy, Combination
-
Female
-
Hepacivirus / drug effects
-
Hepatitis C, Chronic / drug therapy*
-
Humans
-
Infant
-
Infant, Newborn
-
Interferon-alpha / therapeutic use
-
Male
-
Retrospective Studies
-
Sustained Virologic Response*
-
Tertiary Care Centers / statistics & numerical data*
Substances
-
Antiviral Agents
-
Interferon-alpha